CFO’s Planned Sell‑Off at Rhythm Pharmaceuticals Raises Flag Over Uncertain Pipeline and Profitability【News Flash】
Insider CFO sells 4,631 Rhythm shares—plan‑based move amid 52‑week highs, negative earnings, and uncertain pipeline milestones.
3 minutes to read